ATP7B and non-small cell lung carcinoma: Researchers have also reported that combining the apoptosis inducer disulfiram with anti-PD-L1 effectively overcomes drug resistance in non-small cell lung cancer (NSCLC) by regulating the ATP7B-mediated HIF-1 signaling pathway (Ryumon et al., 2019).